Cardiac markers in acute coronary syndrome

Area of Science:

• Cardiology
• Biomarkers
• Clinical Diagnostics

Background:

• Acute coronary syndrome (ACS) diagnosis relies on various clinical factors.
• Serum cardiac markers have significantly evolved, offering insights into ACS pathophysiology.
• Current markers assess platelet activation, ischemia, inflammation, and myocardial damage.

Purpose of the Study:

• To review the expanding role of serum cardiac markers in managing acute coronary syndrome.
• To highlight the utility of these markers in diagnosis, prognosis, triage, and treatment.
• To identify future challenges in optimizing marker selection for patient outcomes.

Main Methods:

• Literature review of recent advancements in cardiac biomarker research.
• Analysis of marker roles in identifying specific pathophysiological processes in ACS.
• Discussion of clinical implications for patient management.

Main Results:

• A substantial increase in available serum cardiac markers for ACS.
• Markers provide critical information on myocardial necrosis, ischemia, and inflammation.
• These markers assist in assessing left ventricular function and platelet activation.

Conclusions:

• Serum cardiac markers are increasingly vital in the acute coronary syndrome (ACS) care pathway.
• The challenge lies in selecting the optimal marker or combination for effective patient management.
• Further research is needed to refine the use of cardiac biomarkers in clinical practice.